Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-08-01
著者
-
Nakamura Tadashi
大阪大学 院分子制御内科学
-
HAYASHI Norio
Department of Biochemistry, Tohoku University School of Medicine
-
Hayashi Noriyuki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
WATABE Kenji
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Osaka University
-
Hayashi Eijirou
大阪大学
-
Hiramatsu Naoki
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Hayashi Norio
大阪大学 医学系研究科消化器内科
-
Hiramatsu Naoki
大阪大学 医学系研究科消化器内科
-
Inoue Yuko
大阪大学 医学系研究科消化器内科
-
Tamura Shinji
大阪大学 医学系研究科消化器内科学
-
Tamba Sachiko
Minoh Municipal Hospital
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University
-
Toyama Tetsuya
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Takehara Tetsuo
京都府立医科大学 消化器内科学
-
Inui Yoshiaki
大阪大学 医学系研究科消化器内科
-
TSUJII Masahiko
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
TSUJI Shingo
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
NISHIDA TSUTOMU
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine
-
Tsuji Shingo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Tsuji Shingo
大阪大学 医学系研究科消化器内科学
-
Tsuji S
Department Of Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Tsuji Shingo
大阪大学 医学部 保健学科 病態生体情報学
-
Tsujii Masahiko
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Tsujii Masahiko
大阪大学 医学系研究科消化器内科学
-
Tsujii M
Department Of Internal Medicine And Therapeutics Osaka University Graduate School Of Medicine
-
Watabe Kenji
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University
-
Watabe Kenji
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Hayashi N
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Tamura S
Osaka University
-
Iio Sadaharu
First Department Of Medicine Osaka University Medical School
-
Kawano S
Department Of Clinical Laboratory Science Osaka University Graduate School Of Medicine
-
Kawano Sunao
Department Of Clinical Laboratory Science School Of Allied Health Sciences Faculty Of Medicine Osaka
-
Hayashi N
Institute Of Gastroenterology Tokyo Women's Medical University
-
ISHII SHUJI
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
IIJIMA HIDEKI
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
-
Iijima Hideki
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Toyama T
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Takehara Tetsuo
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Tamura Shinji
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University Medical S
-
Hayashi Naoaki
Division Of Medicine Institute Of Gastroenterology Tokyo Women's Medical University
-
Hayashi Norio
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Nishida Tsutomu
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Tamura Shinji
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University
-
Ishii Shuji
Department Of Gastroenterology And Hepatology (k1) Osaka University Graduate School Of Medicine
-
Hayashi Nobuhiko
Department Of Gastroenterology And Hepatology Osaka University Graduate School Of Medicine
-
Kawano Sunao
Department Of Clinical Laboratory Science Osaka University Graduate School Of Medicine
-
Hayashi Norio
Department Of Biochemistry Tohoku University School Of Medicine
-
Hayashi Norio
Department Of Gastroenterology And Hepatology Graduate School Of Medicine Osaka University
-
Hayashi Nobuhiko
Department Of Gastroenterology Osaka University
-
Hiramatsu Naoki
First Department Of Medicine Osaka University School Of Medicine
-
Nishihara Tamao
Department Of Internal Medicine Hyogo Prefectural Nishinomiya Hospital
-
Nishida Tsutomu
Department Of Internal Medicine Hyogo Prefectural Nishinomiya Hospital
-
Hayashi Norio
Department Of Biochemistry School Of Medicine Tohoku University
-
Hayashi Norio
The 1st Department Of Medicine Osaka University Medical School
-
TAKEHARA Tetsuo
Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
関連論文
- The Promoter of Mouse Transcription Repressor bach1 Is Regulated by Sp1 and Trans-Activated by Bach^1
- Conserved Structure, Regulatory Elements, and Transcriptional Regulation from the GATA-1 Gene Testis Promoter^1
- Multi-Slice Computed Tomography, a New Device for Percutaneous Coronary Intervention for Chronic Total Occluded Lesion(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 11 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulatio
- Stent Expansion Index in Native Coronary Arteries with Multi-slice Intravascular Ultrasound Analysis(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 11 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Coronary Stent Perforation High Risk Sign in Intravascular Ultrasound, Japanese Registry Study(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C
- A novel therapeutic strategy with anti-CD9 antibody in gastric cancers
- Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
- Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization
- Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
- Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
- Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
- Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
- Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
- Clinical Significance of High-Molecular Weight Form of Adiponectin in Male Patients With Coronary Artery Disease
- Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C
- Reduced expression and functional impairment of Toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection
- OE-350 The Influence of Wire Cross Pattern on Subsequent Outcome in CTO-PCI(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD) : OE44)(Oral Presentation (English))
- OE-348 Optimal Stenting in the Situation of LCX Jail(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 13 (IHD) : OE44)(Oral Presentation (English))
- Molecular Pathogenesis of Viral Hepatitis
- Should aged patients with chronic hepatitis C be treated with interferon and ribavirin combination therapy?
- The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
- Juvenile hepatocellular carcinoma with congestive liver cirrhosis
- Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
- Efficacy of combination therapy of interferon-α with ursodeoxycholic acid in chronic hepatitis C: A randomized controlled clinical trial
- Expression of Rab5a in hepatocellular carcinoma : Possible involvement in epidermal growth factor signaling
- Development of complementary expression patterns of E- and N-cadherin in the mouse liver
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
- Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum γ-glutamyltranspeptidase levels
- Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
- Sequencing analysis of the terminal protein region in patients showing persistent remission of chronic hepatitis B
- IS HELICOBACTER PYLORI-INDUCED ENLARGED FOLD GASTRITIS A HIGH-RISK FACTOR FOR GASTRIC CARCINOMA?
- Changes in serum hepatic fibrosis markers in biochemical responders to interferon therapy for chronic hepatitis C
- Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
- Pretreatment viral load and response to interferon therapy for liver cirrhosis caused by hepatitis C virus: a multicenter controlled study
- Clinical efficacy and immunological effects of weekly administration of interferon-β in patients with type B chronic hepatitis
- Effect of glycyrrhizin on viral replication and quasispecies in patients with type C chronic hepatitis
- Retreatment with 24-week course of interferon-α for patients with chronic hepatitis C
- Binding cells of ^I-iodoamphetamine in rat liver
- Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease : a multicenter experience
- Foods and beverages in relation to urothelial cancer : Case-control study in Japan
- Cultured bone marrow cell local implantation accelerates healing of ulcers in mice
- Colonic mucosal hemodynamics and tissue oxygenation in patients with ulcerative colitis: Investigation by organ reflectance spectrophotometry
- Effects of interferon-γ and-β in treatment of chronic hepatitis B
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas
- Hypervascular hepatocellular carcinoma : Combined dynamic MDCT and SPIO-enhanced MRI versus combined CTHA and CTAP
- Restoration of gut motility in Kit-deficient mice by bone marrow transplantation
- Efficiency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats
- Involvement of bone marrow-derived cells in healing of experimental colitis in rats
- Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice
- New chemotherapy for patients with advanced hepatocellular carcinoma : Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy
- Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
- 5-Aminolevulinate Synthase Expression and Hemoglobin Synthesis in a Human Myelogenous Leukemia Cell Line^1
- Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
- Involvement of GBV-C/HGV in liver diseases in Japan
- Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells
- Semiautomated volumetry of the cerebrum, cerebellum-brain stem, and temporal lobe on brain magnetic resonance images
- Adiponectin deficiency enhanced the severity of cerulein-induced chronic pancreatitis in mice
- Diffuse Cavernous Hemangioma of the Rectum : Report of a Case
- Diffuse cavernous hemangioma of the rectum: MR imaging with endorectal surface coil and sphincter-saving surgery
- Role of the Heme Regulatory Motif in the Heme-Mediated Inhibition of Mitochondrial Import of 5-Aminolevulinate Synthase
- Endoscopic follow-up study of development of gastric antral vascular ectasia associated with liver cirrhosis
- Little expression of proto-oncogene Bcl-2 in tumourous cells of hepatocellular carcinoma with chronic heatitis C virus infection
- Structure, Expression and Chromosome Mapping of MLZE, a Novel Gene Which Is Preferentially Expressed in Metastatic Melanoma Cells
- Annexin VII as a Novel Marker for Invasive Phenotype of Malignant Melanoma
- Changes in virus loads and precore mutations in chronic hepatitis B patients treated with 4 weeks of daily interferon alfa-2a therapy
- Thrombotic thrombocytopenic purpura developed suddenly during interferon treatment for chronic hepatitis C
- Hepatitis C virus 1b(II) Infection and Development of Chronic Hepatitis, Liver Cirrhosis and Hepatocellular Carcinoma : a Case-Control Study in Japan
- Antiviral therapy for chronic hepatitis C : past, present, and future
- Measuring immunity in viral hepatitis
- Disappearance of serum HCV-RNA after short-term prednisolone therapy in a patient with chronic hepatitis C associated with autoimmune hepatitis-like serological manifestations
- The Effect of Cytokines on the Differentiation of an Eosinophilic Leukemia Cell Line (EoL - 1) is Associated with Down Regulation of c-myc Gene Expression
- Numerical Characterization of Dosimetry, Human Body Resistance and Heart Current Resulting from Power-Frequency Touch Current for an Anatomically Realistic Human Model
- Fas and Fas ligand in human hepatocellular carcinoma
- Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
- Development of a Method for Reconstructing Three-dimensional Data from Axial, Sagittal, and Coronal MR Images
- STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo
- Adipocytokines and liver disease
- Molecular Pathogenesis of Viral Hepatitis
- Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
- SHORT-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) FOR EARLY GASTRIC NEOPLASM : MULTICENTER SURVEY BY OSAKA UNIVERSITY ESD STUDY GROUP
- Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term low-dose aspirin therapy : results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
- Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia : a multicenter study by Osaka University ESD Study Group
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
- Efficacy of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan
- Differential alteration of CD56^ and CD56^ natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- Efficacy of pegylated interferon plus ribavirin combination therapy for hepatitis C patients with normal ALT levels : a matched case-control study
- Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients
- Association of low serum adiponectin levels with erosive esophagitis in men : an analysis of 2405 subjects undergoing physical check-ups
- Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection
- Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy : results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
- Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
- Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines
- Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection